NiKang Therapeutics Announces Completion of $200 Million Series C Financing to Advance Highly Differentiated Small Molecules Addressing Difficult-to-Drug Targets
Bing Yao, Ph.D., former chief executive officer and chairman of Viela Bio, and Ting Jia,…
Visa and SFHK Unlock Tap to Pay, Elevating Doorstep Pickup and Delivery Payment Experience
‘Doomsday: Last Survivors’ Unleashes Growth Potential as Gross Billings Hit Record Highs
SunScout Dual-Lists on NYSE American and NYSE Texas After Raising $15.5 Million
SunScout Debuts on NYSE, Aiming at $4.7 Billion Global Robotic Mower Market
36th Food Expo opens today